Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

TY - JOUR

T1 - Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

AU - Jones, T. M.

AU - Johnson, S. W.

AU - DiMondi, V. P.

AU - Wilson, D. T.

PY - 2016/6/7

Y1 - 2016/6/7

UR - https://cufind.campbell.edu/pharmacypractice/1085

UR - https://doi.org/10.2147/IDR.S105620

U2 - 10.2147/IDR.S105620

DO - 10.2147/IDR.S105620

M3 - Article

C2 - 27354817

VL - 9

JO - Infection and Drug Resistance

JF - Infection and Drug Resistance

ER -